HTLV-1-associated inflammatory myopathies: Low proviral load and moderate inflammation in 13 patients from West Indies and West Africa

Journal of Clinical Virology

Volumn 57, Issue 1, 2013, Pages 70-76

  Desdouits, Marion ^a,b,c   Cassar, Olivier ^a,b   Maisonobe, Thierry ^d   Desrames, Alexandra ^a,b   Aouba, Achille ^e   Hermine, Olivier ^e   Mikol, Jacqueline ^f   Polivka, Marc ^f   Penisson Besnier, Isabelle ^g   Marcorelles, Pascale ^h   Zagnoli, Fabien ⁱ   Papo, Thomas ^j   Lacour, Arnaud ^k   Amoura, Zahir ^d   Haroche, Julien ^d   Cherin, Patrick ^d   Teixeira, Antonio ^d   Benveniste, Olivier ^d   Herson, Serge ^d   Morin, Anne Sophie ^l   Mortreux, Franck ^m   Wattel, Eric ^m   Huerre, Michel ^a   Cumont, Marie Christine ^a   Martin Latil, Sandra ^a,b   Butler Browne, Gillian ^d   Gout, Olivier ⁿ   Taylor, Graham ^o   Gessain, Antoine ^a,b   Ozden, Simona ^a,b   Ceccaldi, Pierre Emmanuel ^a,b,c   more..

^a INSTITUT PASTEUR   (France)

^b Institut Pasteur   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f HÔPITAL LARIBOISIÈRE   (France)

^g ANGERS UNIVERSITY HOSPITAL   (France)

^h BREST UNIVERSITY HOSPITAL   (France)

ⁱ Military Teaching Hospital Clermont Tonnerre   (France)

^j BICHAT HOSPITAL   (France)

^k LILLE UNIVERSITY HOSPITAL   (France)

^l BEAUJON HOSPITAL   (France)

^m UNIVERSITÉ LYON 1   (France)

ⁿ FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD   (France)

^o ST MARY S HOSPITAL   (United Kingdom)

more..

Author keywords

HTLV; Muscle; Myopathy; Myositis

Indexed keywords

AMLODIPINE; CORTICOSTEROID; HUMAN T CELL LEUKEMIA VIRUS ANTIBODY; IMMUNOGLOBULIN; INTERFERON; SALAZOSULFAPYRIDINE;

ADULT; AFRICA; AGED; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CARIBBEAN ISLANDS; CLINICAL ARTICLE; DNA EXTRACTION; ENDEMIC DISEASE; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS TYPE 1 ASSOCIATED INFLAMMATORY MYOPATHY; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOLOGY; IN SITU HYBRIDIZATION; MALE; MUSCLE BIOPSY; MYOSITIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TISSUE INJURY; VIRUS LOAD;

ADULT; AFRICA, WESTERN; AGED; AGED, 80 AND OVER; FEMALE; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MYOSITIS; PHYLOGENY; PROVIRUSES; RETROSPECTIVE STUDIES; RNA, MESSENGER; RNA, VIRAL; STATISTICS, NONPARAMETRIC; VIRAL LOAD; WEST INDIES;

EID: 84875807077     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2012.12.016     Document Type: Article

References (36)

1. Gessain A., Cassar O. Epidemiological Aspects and world distribution of HTLV-1 infection. Front Microbiol 2012, 3:388.
2. Proietti F.A., Carneiro-Proietti A.B., Catalan-Soares B.C., Murphy E.L. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005, 24:6058-6068.
3. Slattery J.P., Franchini G., Gessain A. Genomic evolution, patterns of global dissemination, and interspecies transmission of human and simian T-cell leukemia/lymphotropic viruses. Genome Res 1999, 9:525-540.
4. Poiesz B.J., Ruscetti F.W., Gazdar A.F., Bunn P.A., Minna J.D., Gallo R.C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980, 77:7415-7419.
5. Gessain A., Barin F., Vernant J.C., Gout O., Maurs L., Calender A., et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985, 2:407-410.
6. Gilbert D.T., Morgan O., Smikle M.F., Simeon D., Barton E.N. HTLV-1 associated polymyositis in Jamaica. Acta Neurol Scand 2001, 104:101-104.
7. Morgan O.S., Rodgers-Johnson P., Mora C., Char G. HTLV-1 and polymyositis in Jamaica. Lancet 1989, 2:1184-1187.
8. Mastaglia F.L., Phillips B.A. Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. Rheum Dis Clin North Am 2002, 28:723-741.
9. Wiendl H. Idiopathic inflammatory myopathies: current and future therapeutic options. Neurotherapeutics 2008, 5:548-557.
10. Dalakas M.C. An update on inflammatory and autoimmune myopathies. Neuropathol Appl Neurobiol 2010.
11. Higuchi I., Hashimoto K., Kashio N., Izumo S., Inose M., Izumi K., et al. Detection of HTLV-I provirus by in situ polymerase chain reaction in mononuclear inflammatory cells in skeletal muscle of viral carriers with polymyositis. Muscle Nerve 1995, 18:854-858.
12. Higuchi I., Hashimoto K., Matsuoka E., Rosales R., Nakagawa M., Arimura K., et al. The main HTLV-I-harboring cells in the muscles of viral carriers with polymyositis are not macrophages but CD4+ lymphocytes. Acta Neuropathol 1996, 92:358-361.
13. Higuchi I., Montemayor E.S., Izumo S., Inose M., Osame M. Immunohistochemical characteristics of polymyositis in patients with HTLV-I-associated myelopathy and HTLV-I carriers. Muscle Nerve 1993, 16:472-476.
14. Ijichi T., Higuchi I., Fukunaga H., Izumo S., Osame M. Lymphocyte subsets in muscle biopsies of human T-lymphotropic virus type I carriers with polymyositis. Intern Med 1992, 31:973-977.
15. Inose M., Higuchi I., Yoshimine K., Suehara M., Izumo S., Arimura K., et al. Pathological changes in skeletal muscle in HTLV-I-associated myelopathy. J Neurol Sci 1992, 110:73-78.
16. Ishii K., Yamato K., Iwahara Y., Eguchi T., Uemura Y., Takehara N., et al. Isolation of HTLV-I from muscle of a patient with polymyositis. Am J Med 1991, 90:267-269.
17. Saito M., Higuchi I., Saito A., Izumo S., Usuku K., Bangham C.R., et al. Molecular analysis of T cell clonotypes in muscle-infiltrating lymphocytes from patients with human T lymphotropic virus type 1 polymyositis. J Infect Dis 2002, 186:1231-1241.
18. Smadja D., Bellance R., Cabre P., Arfi S., Vernant J.C. Clinical characteristics of HTLV-1 associated dermato-polymyositis. Seven cases from Martinique. Acta Neurol Scand 1995, 92:206-212.
19. Wiley C.A., Nerenberg M., Cros D., Soto-Aguilar M.C. HTLV-I polymyositis in a patient also infected with the human immunodeficiency virus. N Engl J Med 1989, 320:992-995.
20. Cupler E.J., Leon-Monzon M., Miller J., Semino-Mora C., Anderson T.L., Dalakas M.C. Inclusion body myositis in HIV-1 and HTLV-1 infected patients. Brain 1996, 119(Pt 6):1887-1893.
21. Littleton E.T., Man W.D., Holton J.L., Landon D.N., Hanna M.G., Polkey M.I., et al. Human T cell leukaemia virus type I associated neuromuscular disease causing respiratory failure. J Neurol Neurosurg Psychiatry 2002, 72:650-652.
22. Matsuura E., Umehara F., Nose H., Higuchi I., Matsuoka E., Izumi K., et al. Inclusion body myositis associated with human T-lymphotropic virus-type I infection: eleven patients from an endemic area in Japan. J Neuropathol Exp Neurol 2008, 67:41-49.
23. Ozden S., Gessain A., Gout O., Mikol J. Sporadic inclusion body myositis in a patient with human T cell leukemia virus type 1-associated myelopathy. Clin Infect Dis 2001, 32:510-514.
24. Illa I., Nath A., Dalakas M. Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: similarities with seronegative polymyositis. Ann Neurol 1991, 29:474-481.
25. Ozden S., Cochet M., Mikol J., Teixeira A., Gessain A., Pique C. Direct Evidence for a chronic CD8+-T-Cell-mediated immune reaction to tax within the Muscle of a human T-Cell leukemia/lymphoma Virus type 1-Infected patient with sporadic inclusion body myositis. J Virol 2004, 78:10320-10327.
26. Jacobson S. Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. J Infect Dis 2002, 186(Suppl. 2):S187-S192.
27. Nagai M., Usuku K., Matsumoto W., Kodama D., Takenouchi N., Moritoyo T., et al. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol 1998, 4:586-593.
28. Cordoliani F., Gessain A., Vignon-Pennamen M.D., Mouly F., Moulonguet I., Flageul B., et al. Adult T-cell lymphoma associated with HTLV-1: a familial form. Ann Dermatol Venereol 1998, 125:708-710.
29. Gessain A., Gout O. Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I). Ann Intern Med 1992, 117:933-946.
30. Tsukasaki K., Hermine O., Bazarbachi A., Ratner L., Ramos J.C., Harrington W., et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol 2009, 27:453-459.
31. Cassar O., Capuano C., Meertens L., Chungue E., Gessain A. Human T-cell leukemia virus type 1 molecular variants, Vanuatu, Melanesia. Emerg Infect Dis 2005, 11:706-710.
32. Cassar O., Capuano C., Bassot S., Charavay F., Duprez R., Afonso P.V., et al. Human T lymphotropic virus type 1 subtype C melanesian genetic variants of the Vanuatu archipelago and Solomon islands share a common ancestor. J Infect Dis 2007, 196:510-521.
33. Gabet A.S., Mortreux F., Talarmin A., Plumelle Y., Leclercq I., Leroy A., et al. High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis. Oncogene 2000, 19:4954-4960.
34. Evans B.K., Gore I., Harrell L.E., Arnold T., Oh S.J. HTLV-I-associated myelopathy and polymyositis in a US native. Neurology 1989, 39:1572-1575.
35. Furukawa Y., Okadome T., Tara M., Niina K., Izumo S., Osame M. Human T-cell lymphotropic virus type-I (HTLV-I)-associated myelopathy/tropical spastic paraparesis with acute type of adult T-cell leukemia. Intern Med 1995, 34:1130-1133.
36. Greenberg S.A., Pinkus G.S., Amato A.A., Pinkus J.L. Myeloid dendritic cells in inclusion-body myositis and polymyositis. Muscle Nerve 2007, 35:17-23.